PharmaCyte Biotech (PMCBD) Stock Price, News & Analysis

Company Overview

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.

Key Stats

• Today's Range: $1.00 to $1.03
• 50-Day Range: $1.01 to $1.27
• 52-Week Range: $5.56 to $55.50
• Volume: 5,146 shs
• Average Volume: 8,831 shs
• Market Capitalization: $1.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PMCBD Stock Analysis - Frequently Asked Questions

How have PMCBD shares performed this year?

PharmaCyte Biotech's stock was trading at $1.55 at the beginning of the year. Since then, PMCBD stock has decreased by 34.8% and is now trading at $1.01.
View the best growth stocks for 2025 here.

How do I buy shares of PharmaCyte Biotech?

Shares of PMCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:PMCBD
• CIK: N/A
• Web: www.pharmacyte.com
• Phone: (917) 595-2850
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.83 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -49.09%
• Return on Assets: -43.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.90
• Quick Ratio: 4.90

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,671,000
• Free Float: N/A
• Market Cap: $1.69 million
• Optionable: Not Optionable
• Beta: 0.27